
Conference Coverage
about 18 hours ago
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trialsabout 19 hours ago
Lung Transplant Trends Shift to Older Adults, Sicker Pediatric Casesabout 21 hours ago
One Treatment, Two Targets: BEAM-302 in AATD: John Hurst, MD, PhDabout 22 hours ago
Why Multidisciplinary Care Drives COPD Biologic SelectionLatest Content

Shorts










Center on Health Equity & Access
All News

Lung transplant candidates are aging rapidly, while cystic fibrosis decline in children shifts pediatric transplant toward sicker, more complex patients.

CMS awarded NY, RI, and MI Rural Health Transformation Program funding to expand rural health care workforce and technology access.

Cleveland heart failure experts discuss the new HFpEF pathway, CKM screening gaps, and drug access barriers.

COPD care gaps, financial strain, and sex disparities negatively impact patient outcomes and quality of life, according to the findings of 2 posters.

Exposure prevention, primary care capacity, and digital health equity all shape the future of respiratory disease care.

Tozorakimab dampened antiviral, allergic, and neutrophilic inflammation pathways in COPD airways, new phase 2a data show.

COPD kills at rates rivaling heart failure and exceeding prostate and breast cancer, per a new study and US mortality data.

PVI for intermittent claudication was associated with more than double the rate of major adverse limb events and higher costs of care.

A deep learning model detected colorectal cancer on noncontrast CT with 86.6% to 88.2% real-world sensitivity.

The action comes after an advisory panel recommended against approval, saying evidence from the did not support a “clinically meaningful benefit."

































